[go: up one dir, main page]

NO976112D0 - 1,6-disubstituted isochromes for the treatment of migraine - Google Patents

1,6-disubstituted isochromes for the treatment of migraine

Info

Publication number
NO976112D0
NO976112D0 NO976112A NO976112A NO976112D0 NO 976112 D0 NO976112 D0 NO 976112D0 NO 976112 A NO976112 A NO 976112A NO 976112 A NO976112 A NO 976112A NO 976112 D0 NO976112 D0 NO 976112D0
Authority
NO
Norway
Prior art keywords
isochromes
migraine
disubstituted
treatment
disubstituted isochromes
Prior art date
Application number
NO976112A
Other languages
Norwegian (no)
Other versions
NO976112L (en
Inventor
Michael D Ennis
Ruth E Tenbrink
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO976112D0 publication Critical patent/NO976112D0/en
Publication of NO976112L publication Critical patent/NO976112L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO976112A 1995-06-30 1997-12-29 1,6-disubstituted isochromes for the treatment of migraine NO976112L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74195P 1995-06-30 1995-06-30
US1123496P 1996-02-06 1996-02-06
PCT/US1996/008681 WO1997002259A1 (en) 1995-06-30 1996-06-07 1,6-disubstituted isochromans for treatment of migraine headaches

Publications (2)

Publication Number Publication Date
NO976112D0 true NO976112D0 (en) 1997-12-29
NO976112L NO976112L (en) 1998-03-02

Family

ID=26668092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO976112A NO976112L (en) 1995-06-30 1997-12-29 1,6-disubstituted isochromes for the treatment of migraine

Country Status (12)

Country Link
EP (1) EP0836599A1 (en)
JP (1) JPH11509532A (en)
AU (1) AU6252296A (en)
BR (1) BR9609631A (en)
CA (1) CA2225282A1 (en)
CZ (1) CZ418597A3 (en)
FI (1) FI974640L (en)
MX (1) MX9710260A (en)
NO (1) NO976112L (en)
PL (1) PL324319A1 (en)
SK (1) SK164297A3 (en)
WO (1) WO1997002259A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2370270A (en) * 2000-12-20 2002-06-26 Lilly Co Eli Pharmaceutical compounds
US7335660B2 (en) 2001-12-19 2008-02-26 Eli Lilly And Company Isochroman compounds for treatment of CNS disorders
GB0130339D0 (en) * 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
US7110576B2 (en) 2002-12-30 2006-09-19 Pitney Bowes Inc. System and method for authenticating a mailpiece sender
BRPI0510642A (en) 2004-05-05 2007-11-20 Hoffmann La Roche arylsulfonyl benzodioxanes useful for modulating 5-ht6 receptor, 5ht2a receptor or both
CN101119989B (en) 2004-12-21 2010-06-09 弗·哈夫曼-拉罗切有限公司 Seman derivatives and their use in the treatment of CNS diseases
AU2005318596B2 (en) 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
ES2314749T3 (en) 2004-12-21 2009-03-16 F. Hoffmann-La Roche Ag DERIVATIVES OF TETRALINA AND INDANO AND USES OF THE SAME AS 5-HT ANTAGONISTS.
KR100899061B1 (en) 2004-12-21 2009-05-25 에프. 호프만-라 로슈 아게 Tetralin and indane derivatives and uses thereof
PL1831159T3 (en) 2004-12-21 2010-06-30 Hoffmann La Roche Tetralin and indane derivatives and uses thereof
RU2008115032A (en) 2005-11-03 2009-12-10 Ф. Хоффманн-Ля Рош Аг (Ch) ARILSULFONILCHROMANES AS 5-NT6 INHIBITORS
EP2041079A1 (en) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Arylsulfonyl naphthalene derivatives and uses thereof
CA2655524A1 (en) 2006-06-20 2007-12-27 F. Hoffman-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
CN102341367B (en) * 2009-03-05 2014-05-07 住友化学株式会社 Method for producing halogen-substituted benzene dimethanol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
NZ277373A (en) * 1993-12-28 1998-07-28 Upjohn Co Iso(thio)chroman-1-ylethylpiperazine and -piperidine derivatives (analogues)

Also Published As

Publication number Publication date
MX9710260A (en) 1998-03-29
FI974640A7 (en) 1997-12-30
CZ418597A3 (en) 1998-06-17
WO1997002259A1 (en) 1997-01-23
FI974640A0 (en) 1997-12-30
FI974640L (en) 1997-12-30
BR9609631A (en) 1999-03-02
AU6252296A (en) 1997-02-05
SK164297A3 (en) 1998-09-09
CA2225282A1 (en) 1997-01-23
NO976112L (en) 1998-03-02
EP0836599A1 (en) 1998-04-22
PL324319A1 (en) 1998-05-25
JPH11509532A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
NO981800D0 (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
NO961483L (en) Process for the treatment of oily formation
NO976112D0 (en) 1,6-disubstituted isochromes for the treatment of migraine
ITTO940748A0 (en) PROSTHETIC CONDUIT PARTICULARLY FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
IL135648A0 (en) Novel 3, 6-hemiketals from the class of 9a-azalides
FI20011433L (en) Process for the preparation of 2,5,diamino-4,6-dichloropyrimidine
IT1292552B1 (en) DEVICE FOR THE APPLICATION OF COATINGS.
FI973173A0 (en) Process for the treatment of condensate
DK0815092T3 (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
NO985535L (en) Process for the preparation of 1,3-alkanediols
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
NO960307D0 (en) Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines
NO179101C (en) Process for the preparation of diblocked 2,3-hydroxymethylcyclobutanol
FI964829A0 (en) Process for the preparation of 2,2,4-trimethyl-1,3-pentanediolisobutyrate
FI930237A7 (en) Process for the preparation of 4,6-dialkoxypyrimidines
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
DK0783491T3 (en) Process for the preparation of 3,3,5-trichloro-glutarimide
NO962812D0 (en) Procedure for the treatment of pneumonia
FI954263A0 (en) For the purposes of this Regulation, the application was made
FI954795A0 (en) For the purposes of this Regulation
FI951660A0 (en) For the purposes of this Regulation
RU95117268A (en) MEANS FOR TREATMENT OF ATOPIC DERMATITIS
FI940088A0 (en) Regulation / Regulation For the purposes of this Regulation, the provisions of this Regulation shall apply
FI20040505A7 (en) Process for the preparation of 1,3-dihydro-6-hydroxy-2H-indol-2-one derivatives
DK0737068T3 (en) 2,3-diaryl-1-benzopyrans for the treatment of dermatitis